News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
325–360
Matches
367
Sources here
20
Companies here
9
Search results Stored financial headlines

Active search

367 matching headlines

Ticker or company: OGNMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Cognex Corporation announces Q2 2026 earnings release date

Cognex Corporation, a leader in industrial machine vision, will announce its second-quarter 2026 financial results on August 5, 2026, after market close. The company will host a conference call on August 6, 2026, at 8:30 a.m. ET to discuss these results. Investors can access …

CGNX main company
Sharemaestro market context Trend signal active 52 weeks +47.4% CGNX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cognex Announces Second Quarter 2026 Earnings Release and Conference Call Dates

Cognex Corporation announced that it will release its second-quarter 2026 earnings on Wednesday, August 5, 2026, after market close. The company will also host a conference call on Thursday, August 6, 2026, at 8:30 a.m. Eastern Time to discuss the results, with details available …

CGNX main company
Sharemaestro market context Trend signal active 52 weeks +47.4% CGNX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cognex Sets Aug. 6 Call to Discuss Second-Quarter Results

Cognex (NASDAQ: CGNX) will release its second-quarter 2026 earnings on Wednesday, August 5, 2026, after market close. The company will host a conference call on Thursday, August 6, 2026, at 8:30 a.m. Eastern Time to discuss the results. Investors can access the live webcast …

CGNX main company
Sharemaestro market context Trend signal active 52 weeks +47.4% CGNX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Samsung Bioepis and Organon Broaden Biosimilar Access in Australia

Samsung Bioepis and Organon have expanded their collaboration in Australia to include an additional biosimilar, deepening their existing partnership. This agreement grants Organon exclusive commercial rights for the new biosimilar in Australia, while Samsung Bioepis retains development, manufacturing, and regulatory responsibilities. The expansion aims …

OGN main company
Sharemaestro market context Trend signal active 52 weeks +46.5% OGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Invesco discloses 28,129,017 Cognizant Technology Solutions (CTSH) shares

Invesco Ltd., a Bermuda-based investment firm, has reported beneficial ownership of 28,129,017 shares of Cognizant Technology Solutions Corp. (CTSH) common stock, which represents 5.9% of the class as of March 31, 2026. The filing indicates that Invesco has sole voting power over 27,766,517 shares …

CTSH main company
Sharemaestro market context Price above Trend Line 52 weeks -17.5% CTSH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cognex resists instruments selloff with 19-week Trend Signal still intact

CGNX added 0.7% in a week when Technology and its instruments peer group both fell more than 4%, but the stock’s 60.5% Fair Value premium and only modest volume confirmation keep the next test important.

CGNX main company
Sharemaestro market context Trend signal active 52 weeks +47.4% CGNX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

William Blair eleva classificação das ações da Cognizant para Outperform devido ao crescimento com IA - Investing.com Brasil

CTSH34 main company
Sharemaestro market context Price below Trend Line 52 weeks -21.5% · Next-week setup negative 44.7% CTSH34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context